Rocket Lab Climbs 5% as Largest-Ever Electron Deal Lifts Backlog Past 100 Missions; AST SpaceMobile Ticks Up, SpaceX Holds Flat

A record Electron launch contract and a new Wall Street initiation reached Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) within hours of each other. It gained a signed deal and fresh bull case. Rocket Lab stock is up 5% to $72.88 in morning trading, leading a space group posting far smaller gains.

Notably, the Procure Space ETF (NASDAQ:UFO) is up 0.3% to $42.46, a muted gain for a fund built around launch providers, satellite operators and aerospace contractors. The SPDR S&P 500 ETF Trust (NYSEARCA:SPY) is up 0.3% to $764.90, a modest advance for U.S. equities that leaves the move in Rocket Lab stock looking clearly company-driven.

Also, AST SpaceMobile (NASDAQ:ASTS) stock is up 2% to $59.80, a smaller gain that trails the advance in Rocket Lab stock. Trading close to flat, SpaceX (NASDAQ:SPCX) stock is up 0.1% to $151.07, even though the contract news landed on a direct launch rival. That muted response from both keeps the spotlight squarely on Rocket Lab.

Record Electron Contract Lifts Backlog Past 100 Missions

Rocket Lab announced a multi-year launch agreement for 20 new Electron missions with Synspective, a Tokyo-based Earth observation company, in a release issued after the previous close. The deal is the biggest commercial launch contract for Electron in Rocket Lab’s history, making Synspective the company’s largest Electron customer, and Synspective’s radar imaging satellites will fly from Rocket Lab’s own launch complex, with the missions scheduled annually later this decade.

Sir Peter Beck, Rocket Lab founder and chief executive, pointed to customer control as the draw. “When constellation builders want control over their destiny, they come to Rocket Lab,” Beck stated in the release. Coming on top of a run of multi-launch contracts awarded this year, the Synspective agreement takes Rocket Lab’s launch backlog beyond 100 missions.

Citigroup Coverage Adds a Fresh Bull Case

Citigroup (NYSE:C) initiated coverage of Rocket Lab stock with a Buy rating and a $105 price target. That timing gives Rocket Lab a signed contract and a new bull case arriving together, the combination that tends to move a company at this stage of its growth. Rocket Lab shares are pricing a backlog event, since the Synspective agreement adds years of contracted Electron work and leaves the current period unchanged.

However, the counter-case for Rocket Lab rests on what the release leaves out. Financial terms of the agreement remain undisclosed, and the missions are scheduled years from now, so the revenue behind Rocket Lab’s backlog is still unknown and distant. Without a contract value, Rocket Lab stock is trading on confidence in future Electron work, which leaves the gain exposed to any shift in sentiment toward long-dated growth stories.

Planet Labs (NYSE:PL) and Synspective share an Earth observation niche. Any follow-on launch deals from imagery operators could extend Rocket Lab’s backlog further past the 100-mission mark.

What to Watch Next

Investors weighing their exposure should adjust their holdings carefully given that the Synspective missions sit years out and Rocket Lab hasn’t put a dollar figure on them. Keeping their share positions moderate fits a growth story that still has to turn signed missions into reported revenue, even with Citigroup’s $105 target as a bullish reference point.

Rocket Lab’s launch backlog beyond 100 missions gives the bull case real substance. Steady execution on those flights may decide how much of that value RKLB stock eventually captures.

Contact [email protected] for any questions or corrections.